84ea5a15-0ad5-4e15-86a7-d671f4fa4796.jpg
+2 more
Tell me about the report
Reading File
analyse_media
analyse_media
analyse_media
Here is a complete breakdown of Ms. Amudha Ganeshan's health reports from MGM Healthcare, dated 13 July 2026.
Patient Summary
- Name: Ms. Amudha Ganeshan
- Age/Gender: 44 years, Female
- Consultant: Dr. Sorubawathy E
- Package: MGM Well Women Check II (40-60 Years)
Abnormal / Concerning Results (Flagged)
🔴 1. Pre-Diabetes / Early Diabetes
| Parameter | Result | Reference | Status |
|---|---|---|---|
| Fasting Glucose | 128.6 mg/dL | 70-110 | HIGH |
| HbA1c | 6.5% | 4-5.7% normal | HIGH |
| Estimated Average Glucose | 139.85 mg/dL | <140 | Near upper limit |
Interpretation: A fasting glucose of 128.6 and HbA1c of 6.5% together indicate diabetes mellitus (ADA criterion: HbA1c ≥6.5% = diabetes). The HbA1c of 6.5% falls in the "Good Control" zone per the report's own diabetes scale, but this is the threshold that diagnoses diabetes in a previously undiagnosed person. This needs urgent attention and formal confirmation/management by her physician.
🔴 2. Vitamin D Deficiency
| Parameter | Result | Reference | Status |
|---|---|---|---|
| 25-Hydroxy Vitamin D3 | 17.35 ng/mL | Sufficient: >30 | DEFICIENT |
Values below 20 ng/mL are classified as deficient. This is common in Indian women and contributes to bone loss, fatigue, and immune issues.
🔴 3. Lipid Profile - Multiple Abnormalities (Dyslipidaemia)
| Parameter | Result | Reference | Status |
|---|---|---|---|
| Total Cholesterol | 211.5 mg/dL | <200 Normal | Borderline High |
| Triglycerides | 180.2 mg/dL | <150 | HIGH |
| HDL Cholesterol | 35.6 mg/dL | >65 No Risk | VERY LOW |
| LDL Cholesterol | 155.3 mg/dL | <100 Optimal | Borderline High |
| VLDL Cholesterol | 36.04 mg/dL | 10-30 | HIGH |
| Cardiac Risk Ratio | 5.94 | 2-4.5 | HIGH |
| Non-HDL Cholesterol | 175.9 mg/dL | 50-130 | HIGH |
Interpretation: This is a significant lipid abnormality pattern. Low HDL + high triglycerides + high LDL + elevated cardiac risk ratio is a classic atherogenic (artery-clogging) profile, especially dangerous in a diabetic patient. The cardiac risk ratio of 5.94 (normal up to 4.5) signals elevated cardiovascular risk.
🔴 4. Fatty Liver (Ultrasound Abdomen)
Impression: Grade II-III Fatty Liver (Non-Alcoholic Fatty Liver Disease / NAFLD)
- Grade II-III is moderate-to-severe fatty infiltration of the liver.
- This is directly linked to her diabetes, high triglycerides, and metabolic syndrome.
- Liver function tests (LFT) are currently all within normal range - bilirubin, AST, ALT, ALP, GGT, proteins, albumin - which is reassuring, but NAFLD can progress to inflammation (NASH) and fibrosis if untreated.
Normal Results
| Parameter | Result | Reference | Status |
|---|---|---|---|
| Urea | 21.9 mg/dL | 16.6-48.5 | Normal |
| BUN | 10.23 mg/dL | 6-20 | Normal |
| Creatinine | 0.74 mg/dL | 0.5-0.9 | Normal (kidneys fine) |
| TSH | 1.16 uIU/mL | 0.27-5.2 | Normal (thyroid fine) |
| Total Bilirubin | 0.41 mg/dL | 0.15-1.3 | Normal |
| AST/SGOT | 19.8 U/L | 5-32 | Normal |
| ALT/SGPT | 30.7 U/L | 5-33 | Normal |
| Alkaline Phosphatase | 66.7 U/L | 35-104 | Normal |
| GGT | 28.1 U/L | 6-42 | Normal |
| Total Protein | 7.2 g/dL | 6-8 | Normal |
| Albumin | 4.5 g/dL | 3.5-5.2 | Normal |
Overall Clinical Picture
Ms. Amudha Ganeshan has findings consistent with Metabolic Syndrome, which is a cluster of conditions occurring together:
- New-onset Diabetes / Pre-diabetes (HbA1c 6.5%, high fasting glucose)
- Dyslipidaemia (high triglycerides, low HDL, high LDL, elevated cardiac risk ratio)
- Grade II-III Fatty Liver (NAFLD on ultrasound)
- Vitamin D deficiency
Despite these metabolic issues, her kidney function, thyroid, and liver enzymes are reassuringly normal at this stage.
Recommended Next Steps (to discuss with her doctor)
- Diabetes management: Formal confirmation, dietary modification, and decision on whether medication (e.g. Metformin) is needed.
- Lipid management: Lifestyle changes (diet, exercise) and likely statin therapy given her cardiovascular risk profile and diabetes.
- Vitamin D supplementation: High-dose Vitamin D3 (typically 60,000 IU weekly for 8-12 weeks, then maintenance).
- Fatty liver follow-up: Weight management, avoid alcohol, repeat ultrasound in 6 months.
- Cardiovascular risk: Given diabetes + dyslipidaemia + fatty liver, a cardiology or internal medicine review is advisable.
Disclaimer: This is an educational interpretation only. All findings and treatment decisions must be reviewed and acted upon by her treating physician, Dr. Sorubawathy E.
This is a shared conversation. Sign in to Orris to start your own chat.